共 50 条
- [2] Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients THERANOSTICS, 2020, 10 (20): : 9364 - 9377
- [5] Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3581 - 3592
- [7] The efficacy and safety of 225Ac-PSMA-617 in metastatic castration-resistant prostate cancer FRONTIERS IN ONCOLOGY, 2025, 15
- [10] 225Ac-PSMA-617-targeted alpha therapy for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis PROSTATE, 2021, 81 (09): : 580 - 591